The information on this website is not intended for diagnosis or treatment. Please consult your physician for health concerns.

Skip to main content

Atrial Fibrillation — DOAC Selection

Choosing the right direct oral anticoagulant for stroke prevention in atrial fibrillation.

Written by: Saygı Hospital Health Guide Editorial Board
Last updated:

This content has been compiled by the Saygı Hospital Health Guide Editorial Board and is periodically reviewed by a specialist physician.

References (5)

This content is for informational purposes only and does not constitute medical advice. You can book an appointment at our Kardiyoloji department. Book Appointment →

What is Atrial Fibrillation — DOAC Selection?

Direct oral anticoagulants (DOACs) are now preferred over warfarin in non-valvular atrial fibrillation for stroke prophylaxis. Available agents include the thrombin inhibitor dabigatran and the factor Xa inhibitors rivaroxaban, apixaban and edoxaban.

Anticoagulation is indicated when the CHA2DS2-VASc score is ≥2 in men or ≥3 in women (≥1 in men, ≥2 in women per current European recommendations). Each DOAC has a distinct dosing schedule, renal-clearance profile and drug-interaction profile that guide individualised selection.

Symptoms

Paroxysmal, persistent or permanent atrial fibrillation
CHA2DS2-VASc score that meets the threshold for anticoagulation
Prior stroke or transient ischaemic attack (secondary prevention)

Risk Factors

Advanced age
Hypertension
Diabetes mellitus
Heart failure
Vascular disease
Previous stroke or TIA

When to See a Doctor?

If you experience any of the following symptoms, seek medical attention promptly:

  • When deciding on anticoagulation at the time of AF diagnosis
  • When DOAC dosing must be adjusted to renal function
  • When a bleeding complication develops
  • When checking for clinically relevant drug interactions

Treatment Methods

01
Apixaban 5 mg twice daily — lowest bleeding risk in most analyses
02
Rivaroxaban 20 mg once daily with food — single-dose convenience
03
Dabigatran 150 mg twice daily — strongest stroke protection but more GI bleeding
04
Edoxaban 60 mg once daily
05
Dose reduction in renal impairment (CrCl <50 mL/min)
06
Annual renal-function review and bleeding-risk reassessment

Which Department to Visit?

You can visit our Kardiyoloji department for these complaints. Our specialist physicians will create the most suitable treatment plan for you.

Learn About Kardiyoloji Department

Let us help you

You can make an appointment with our specialists or contact us for your concerns.

Health Disclaimer: The information on this page is prepared for general informational purposes only. It does not replace medical diagnosis and treatment. Please consult your physician for your complaints. Saygı Hospital does not accept responsibility for actions taken based on the information on this page.